Profil
Göran Tornling currently works at AcuCort AB, as Independent Director from 2021, Karolinska Institutet, as Associate Professor, Biolipox AB, as Chief Medical Officer & Vice President from 2006, and AnaMar AB, as Chief Medical Officer.
Dr. Tornling also formerly worked at AstraZeneca R&D Boston, Inc., as Director-Medical Science.
Dr. Tornling received his doctorate degree from Karolinska Institutet.
Aktiva positioner av Göran Tornling
| Företag | Position | Start |
|---|---|---|
| ACUCORT AB | Direktör/Styrelseledamot | 2021-01-01 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Teknisk/Vetenskaplig/F&U Direktör | 2006-09-01 |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Göran Tornling
| Företag | Position | Slut |
|---|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Företagsledare/Principal | - |
Göran Tornlings utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
















